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ABSTRACT                                                                                                                                                                                                
BACKGROUND: Toxoplasmosis is an infection caused by the protozoan Toxoplasma gondii. It is common in severely immune-
compromised persons.                                                                                                         
OBJECTIVE: To determine the seroprevalence of T. gondii infection and the risk factors associated with the infection and to 
investigate the association between T. gondii infection and CD4 cell count.                                                                                                       
METHODS: Sera collected from 242 HIV positive HAART- naïve patients were tested for T. gondii specific immunoglobulin G 
antibodies. Information was obtained using a structured questionnaire. Baseline CD4 cell counts were obtained from patients’ 
case files. Data was managed using SPSS version 20 software and Microsoft Excel worksheet.   
RESULTS: One hundred and sixty eight (69.4%) subjects were females while 74(30.6%) were males. One hundred (41.3%) of 
study participants were Toxoplasma IgG antibody positive. Thirty two(32) HIV positive pregnant women were among this 
group studied with 12( 37.5%) being Toxo IgG antibody positive. Toxoplasma seropositivity was higher in females (42.8%) than 
in males (39.2%), P= 0.60. CD4 cell count level of < 200 was negatively associated with Toxoplasma seropositivity than CD4 
count ≥ 200 by logistic regression (OR= 0.6; 95% CI 0.3- 1.0). Living in proximity with cat was positively associated with T. gondii
infection (P= 0.01). 
CONCLUSION: T. gondii infection is common in pregnant women indicating greater probability of congenital transmission of 
T. gondii. This could form a basis for recommending intensifying health education and prophylactic treatment for all HIV 
positive pregnant women. Measures should be taken to prevent stray cats from entering homes. 
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RÉSUMÉ
Contexte: La toxoplasmose est une infection causée par le protozoaire Toxoplasma gondii . Il est fréquent chez les personnes 
gravement immunodéprimées. Objectif: Déterminer la séroprévalence de l’infection à T. gondii et les facteurs de risque associés 
à l'infection et à étudier l'association entre l'infection par T. gondii et la numération des CD4. Méthodes: Les sérums prélevés à 
partir de 242 sujets séropositifs au VIH et naïfs au HAART ont été testés pour des anticorps immunoglobulines G spécifiques 
de T. gondii. L'information a été obtenue à l'aide d'un questionnaire structuré. Le nombre de cellules CD4 de base ont été 
obtenus à partir des dossiers des patients. Les données ont été analysées avec les logiciels SPSS version 20 et Microsoft Excel.
Résultats : Cent soixante-huit (69,4%) sujets étaient des femmes alors que 74 (30,6 %) étaient des hommes. Cent (41,3 %) des 
participants à l'étude étaient positif à des anticorps IgG de Toxoplasma. Trente deux (32) femmes enceintes séropositives ont été 
parmi ce groupe étudié avec 12 (37,5%) étant anticorps IgG Toxo positive. La séropositivité de Toxoplasma était plus élevé chez 
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les femmes (42,8%) que chez les hommes (39,2%), P = 0,60. Le niveau de CD4 < 200 a été négativement associé à la séropositivité 
de Toxoplasma que le comptage de CD4 ≥ 200 par régression logistique (OR = 0,6, IC 95% 0,3-1,0). Vivre à proximité du chat était 
positivement associée à l'infection par T. gondii (P=0,01).
Conclusion: L'infection à T. gondii est commune chez les femmes enceintes indiquant une plus grande probabilité de la 
transmission congénitale de T. gondii. Cela pourrait constituer une base pour recommander l'intensification de l'éducation 
sanitaire et le traitement prophylactique pour toutes les femmes enceintes séropositives. Des mesures devraient être prises pour 
empêcher les chats errants de pénétrer dans les habitations.
Mots-clés: Toxoplasma gondii , IgG , séroprévalence , VIH positif , les cellules CD4
INTRODUCTION                                                                    
Toxoplasmosis is a disease caused by the protozoan
Toxoplasma gondii, which affects humans in the brain 
causing Toxoplasma encephalitis and other organs like 
eyes and lungs. T. gondii encephalitis could be via 
acute infection or reactivation of latent infection 
among immune suppressed persons including those 
with acquired immuno-deficiency syndrome, those 
with immunosuppressive cancer and transplant 
recipients on immunosuppressive drugs. 
Toxoplasmosis occurs in 3-10% patients in USA and 
up to 50% of patients in Europe and Africa (1). In 
patients with AIDS, CNS involvement is the most 
common manifestation, ranging from nonspecific, 
generalized symptoms to focal findings such as 
headache, altered levels of consciousness, motor 
impairment, and seizures. Seizures was reported as 
an early manifestation of cerebral toxoplasmosis (2). 
Various studies have revealed different incidences; 
12-25% toxoplasmosis in HIV infected persons (2, 3). 
Adults with normal immune function are usually 
asymptomatic or might have symptoms such as fever, 
malaise and lymphadenopathy that resolve 
spontaneously. The disease is rare among HIV 
positive people with T- cell counts of above 200 and 
most common among HIV positive people with T-
cell count below 50(4). Similar study by Jacques et al.,
2006 reported a strong association of T. gondii
seroprevalence with HIV serostatus. Nahlen et al.,
(1992) (6) also associated very low CD4+ cell counts 
with CNS toxoplasmosis in HIV/AIDS.
Congenital Toxoplasmosis is the most serious form of 
human infection. Intra-uterine infection with T. gondii
due to active parasitaemia during pregnancy can 
cause severe and fatal damage to a foetus. Fetal 
infection with T gondii may result in stillbirth or 
abortion. Infection could also lead to fetal brain 
damage or mental retardation, blindness, and 
epilepsy in infancy or much later in life. CNS 
involvement with Toxoplasma gondii is uncommon in 
HIV infected children. Rate of transplacental 
transmission has been reported to be 55% for 
untreated mothers and 25% for treated mothers (7).
Approximately 10-20% of pregnant women infected 
with T. gondii show clinical signs. Congenital infection 
is most severe if acquired in the first or, in some cases, 
second trimester. Infection during the second or third 
trimesters tends to be asymptomatic. Seventy-five 
percent of infants born with congenital toxoplasmosis 
infection are asymptomatic. Eight percent show 
severe CNS impairment, which might not manifest 
for several years.
Serologic prevalence data indicate toxoplasmosis as 
one of the most common human infections 
throughout the world, more common in warm 
climates. Prevalence of 25.3% was reported in 
pregnant women in Burkina Faso (5), 22.5% in USA 
with 15% seroprevalence found among women of 
child bearing age (8). Seroprevalence in Nigeria was 
reported as 78% among pregnant women in Ibadan 
(9) and 83% in the population of South Delta in 
Nigeria (10).
Common sources of this infections are: eating of raw 
or undercooked meat containing T. gondii tissue cysts 
or eating food that has been cross- contaminated; 
ingesting of oocysts from soil through gardening, 
handling and eating unwashed vegetables or 
changing a cat litter box, through placenta (congenital 
infection), and through sexual contact as suggested by 
Jacques et al., 2006 in the study of HIV, HBV, HCV 
and T. gondii co-infection. Studies revealed presence 
of T. gondii antibodies in the animal populations and 
suggested that toxoplasmosis is a widely spread 
zoonotic infection(11, 12, 13). 
Evidence has shown T. gondii infection to cause 
complication in children born of HIV infected 
pregnant woman, with latent infection reactivated 
when immunity is suppressed. This poses a serious 
health threat especially in our country Nigeria with 
high prevalence of HIV/AIDS. Hence the need for the 
study in HIV/AIDS patients in our clinic and this 
could form a basis for primary prophylaxis.
Objectives
1. Determine the prevalence of toxoplasmosis 
in HIV patients including pregnant women.
2. Identify risk factors to toxoplasmosis in HIV 
patients.
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3. To find association between toxoplasmosis 
and T cell counts.
MATERIALS AND METHODS 
Study centre
This study was conducted at the HIV counseling and 
testing (HCT) unit of the outpatient clinic, Nigerian 
Institute of Medical Research, Yaba, Lagos. It is one of 
the clinics implementing the federal government of 
Nigeria anti-retroviral (ARV) access programme with 
support from Havard School of public health. HIV 
care, treatment and support is given at the center.
Sample size
242 consenting individuals attending the clinic for
the first time was recruited in the study. This was 
estimated using the standard cross-sectional sample 
size formula where P is the expected prevalence rate, 
Z the value of the reference normal distribution for 
the desired confidence level (1.96) for 95% confidence 
level. D is the highest acceptable error in the estimate.
n = Z2 [ P (1-P) ];   D2  ;  P = 83%( 0.83);               
Z = 1.96 ;  D = 5% (0.05)
Inclusion criteria and Exclusion criteria                                                                                                                                             
All new HIV positive males and females including 
pregnant women were included in this study, 
however non- consenting HIV positive patients and 
infants of < 18 months were excluded.
Ethical clearance
Nigerian Institute of Medical Research ethical review 
board approved the study.
Study design                                                                                                                                                                    
A cross-sectional study of 242 participants was 
conducted from April, 2009 to April, 2012 in Anti-
retroviral (ARV) clinic, N.I.M.R Yaba, Lagos. Data 
was collected from individuals on first visit to assess 
anti-retroviral treatment from ARV clinic, NIMR.  
Data Collection                                                               
A structured questionnaire was administered to each 
consenting participant to assess the socio-
demographic characteristics, variable risk factors to 
Toxoplasma gondii infection by the individual. T- Cell 
count of each individual was extracted from the 
patient’s clinic folder in order to evaluate its 
association with laboratory findings. 
Laboratory Procedure                                  
2mls blood sample was collected at the HCT centre of 
NIMR. This was followed by laboratory analysis of 
the samples; the serum was tested for IgG antibody to 
Toxoplasma gondii using Toxoplasma ELISA- based 
test kit (TECO Diagnostics, USA ).
Data management                                                                                                              
Data was entered and analysed using SPSS 20 
software. 
RESULTS                                                                                          
Of the 242 HIV positive patients tested between 2009 
and 2012, 100 (41.5%) were positive for T. gondii IgG 
antibody. Toxoplasmosis prevalence by sex, age 
group, ethnic group and level of education is shown 
in table 1. Toxoplasma gondii IgG seroprevalence 
decreased across the group with age group < 21-30 
being the highest (58.9%). The prevalence was also 
higher in females (42.8%) than in males (39.2%). 
Among 32 HIV-positive pregnant women, 12(37.5%) 
were positive for T. gondii IgG antibody. Only the 
factor, ‘living in proximity with cats’ was significantly 
associated with T. gondii seropositivity (Table 2). 
However, Mean CD4 count was 273 cells/µl; Min-   6  
cells/µl, Max- 1407cells/µl. CD4 level of <200 was a 
greater predictor of seropositivity than ≥ 200 by
logistic regression analysis (OR = 0.6; 95% C.I 0.3 –
1.0).
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Prevalence N (%) P- value
Sex          Male




Ethnic group     
Hausa
                          
Igbo
                         
Yoruba
                         








Prevalence N (%) P- value
Level of 
Education    
None
                                    
Primary
                                    
Secondary







TABLE 2: RISK FACTORS OF TOXOPLASMOSIS
Risk factors Frequency 
(%)
P- value
Sex partners Faithfulness 74 (40.2) 0.103
> 1 partner 17 (45.0)
None 8 (36.4)














Yes 1 (33.3) 0.768
No 99 (41.8)
Indulge in Yes 6 (40) 0.881
gardening No 94 (42)
Soil related 
occupation





Yes 12 (40) 0.843
No 88 (41.9)
Eat unwashed 
veg. and fruits 
outside home
















Pure water 11 (50)
Boil, filter or 
use water 
guard
Yes 42 (38.2) 0.314
No 58 (44.6)
DISCUSSION                                                                                                                                                                                                      
From the result, the prevalence was higher in females 
than in males; with majority (89%) of the females 
from this study being of childbearing age. This 
suggests that pregnant women should take 
appropriate precautions to protect themselves against 
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this infection. Such precautions include cooking meat, 
especially lamb and pork, until it is well done; 
thorough washing of cutting boards used to prepare 
meat; wearing gloves when gardening; rigorous hand 
washing after handling raw meat or working in the 
soil; and avoiding contact with cat feces. From this 
study, 37.5% of the pregnant women were positive to 
T. gondii IgG antibody. We were not able to confirm 
recent infection in the women using anti- T. gondii
IgM for possible congenital transmission. However, 
IgG avidity testing is the preferred method to confirm 
recent infection (14), because IgM antibodies can 
persist for months after initial infection in some 
individuals. It have been shown that 43 cases of 
toxoplasmosis acquired during pregnancy would be 
expected to result in 11–21 cases of congenital 
toxoplasmosis, assuming a 25–50% probability of 
transmission to the fetus in the uterus (15).     
The T.gondii IgG seroprevalence (41.5%) from this 
study was similar to that (38.8%) obtained in Jos, 
Nigeria (16) among HIV positive individuals. 
Prevalence of 37.5% observed in pregnant women 
was higher than what was obtained in pregnant 
women (25.3%) in Burkina Faso (5) and 22.5% in USA 
(8). However, our result is lower than what was 
obtained (78%) among pregnant women in Ibadan, 
Nigeria (9) and 83% in the population of South Delta 
in Nigeria (10). It could be an improvement in the 
control strategies against Toxoplasma gondii infection 
that brought about the reduction in prevalence in the 
high risk group.    Highest prevalence obtained in the 
lower age group as was highlighted by Papoz et al., 
(1986) probably reflected soil exposure to T. gondii
oocysts. Living in proximity with cat was positively 
associated with T. gondii seropositivity. Others studies 
have associated eating of rodents, having soil related 
occupation (16), cat ownership etc. with 
seropositivity. This is understandable because in our 
environment, most people do not own cats (table 2) 
but we see cats gaining access to people’s homes 
especially in the night where they look for leftover 
food leaving their droppings to contaminate the 
surfaces. It is encouraging to note the hygienic 
practice of the study participants and these goes to 
show that infection in this group would have been 
from eating of improperly cooked meat/ meat 
products, vegetables and fruits, though it was not 
significant, especially outside home.      Earlier studies 
have acclaimed that the disease is rare among HIV 
positive people with T- cell counts of above 200 and is 
most common among HIV positive people with T-
cell count below 50( 4). T- cell count group < 200 from 
this study is associated to T. gondii seropositivity than 
above or equal to 200.     
In conclusion, T. gondii infection is common in 
pregnant women indicating greater probability of 
congenital transmission of T. gondii. This could form a 
basis for recommending intensifying health education 
and prophylactic treatment for all HIV positive 
pregnant women. Screening of newborns over a 
specified time period could elucidate the true burden 
of congenital toxoplasmosis. Measures should also be 
taken to prevent stray cats from entering homes.
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